Kevin J. Ballinger, SVP & President, Interven Cardio at BOSTON SCIENTIFIC CORP (BSX), sold 3,285 shares at $17.48 ($57K) on 2016-02-25, disclosed to the SEC on 2016-02-26.
Scheduled sale ($57k) by SVP & President, Interven Cardio under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.33 | 1,382 | $24K | 41.9% |
| 2 | $17.48 | 1,903 | $33K | 58.1% |
| Total | $17.42 avg | 3,285 | $57K | 100% |
| Filing → |
| BSX | SELL | 2020-03-03 | $1.2M | — | Filing → |
| BSX | SELL | 2020-02-26 | $466K | — | Filing → |
| BSX | SELL | 2020-02-19 | $149K | — | Filing → |